Objectives Diabetes is associated with adverse outcomes, including death, after coronavirus
disease 19 (COVID-19) infection. Beyond the lungs, Severe Acute Respiratory Syndrome …

Elevated angiotensin-converting enzyme 2 (ACE2) expression in organs that are potential
targets of severe acute respiratory syndrome coronavirus 2 may increase the risk of …

Aims Angiotensin-converting enzyme 2 (ACE2) is the cellular entry point for severe acute
respiratory syndrome coronavirus (SARS-CoV-2)—the cause of coronavirus disease 2019 …

Hypertension emerged from early reports as a potential risk factor for worse outcomes for
persons with coronavirus disease 2019 (COVID-19). Among the putative links between …

Background Individuals with chronic kidney disease are affected by acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) due to multiple comorbidities and altered immune …

COVID-19 morbidity and mortality are increased in patients with diabetes and kidney
disease via unknown mechanisms. SARS-CoV-2 uses angiotensin-converting enzyme 2 …

After the outbreak of severe actute respiratory syndrom coronavirus (SARS-CoV) in 2003, it
was shown that angiotensin converting enzyme 2 (ACE2) was the receptor for this …

In the early months of the coronavirus disease 2019 (COVID-19) pandemic, a hypothesis
emerged suggesting that pharmacologic inhibitors of the renin–angiotensin system (RAS) …

The causes of the increased risk of severe coronavirus disease 2019 (COVID-19) in people
with diabetes are unclear. It has been speculated that renin-angiotensin system (RAS) …

In late 2019, a coronavirus disease (COVID-19) leading to severe acute respiratory
syndrome (SARS) started in China and has become a pandemic. The responsible virus has …